• KOL
    • Glucocorticoid Receptor
    • Frank H De Jong
    • Frank H de Jong: Influence Statistics

      Frank H de Jong

      Frank H de Jong

      Show email address

      Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands | Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Frank H de Jong:Expert Impact

      Concepts for whichFrank H de Jonghas direct influence:Glucocorticoid receptor,Sertoli cells.

      Frank H de Jong:KOL impact

      Concepts related to the work of other authors for whichfor which Frank H de Jong has influence:Ovarian reserve,Polycystic ovary syndrome,Prostate cancer,Glucocorticoid receptor,Sertoli cells,Antimüllerian hormone,Amh levels.

      KOL Resume for Frank H de Jong

      Year
      2022

      Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands

      2021

      Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

      2019

      Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, CA, Netherlands

      2018

      Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

      2017

      Department of Internal Medicine, Section of Endocrinology, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands

      2016

      Division of Human Genetics, Center for Biomedical Research Faculty of Medicine Diponegoro University (FMDU), Semarang, Indonesia.

      2015

      Department of EpidemiologyErasmus Medical Center, PO Box 2040, 3000CA Rotterdam, The NetherlandsThe Health Care InspectorateThe Hague, The NetherlandsDepartments of Internal MedicineClinical ChemistryErasmus Medical Center, Rotterdam, The NetherlandsHospital PharmacyThe Hague Hospitals - HAGA, The Hague, The Netherlands.

      2014

      Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands

      2013

      Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands

      2012

      Department of Internal Medicine (L.M., J.W.K., F.H.d.J., R.A.F., E.F.C.v.R.), Division of Endocrinology, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands

      2011

      Department of Internal Medicine (F.H.d.J.), Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands

      2010

      Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands

      2009

      Departments of, Clinical Genetics, Pathology, Reproduction and Development, Internal Medicine and, Pediatric Endocrinology, Sophia Children’s Hospital, Erasmus MC, Rotterdam, The Netherlands;, Division of Human Genetics, Center for Biomedical Research and, Department of Urology, Faculty of Medicine, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia

      Department of Internal Medicine (F.H.d.J.), Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands

      2008

      Department of Internal Medicine, Section of Endocrinology, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands

      2007

      Section of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands

      2006

      Department of Internal Medicine, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, The Netherlands

      2005

      Department of Internal Medicine, Erasmus University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, the Netherlands,

      2004

      Departments of Internal Medicine (H.W.G.-P., M.v.d.K., W.d.R., F.H.d.J., H.A.P.P.), 3000 DR Rotterdam, The Netherlands

      2003

      Department of Internal Medicine, University Hospital Dijkzigt, Rotterdam, the Netherlands

      2002

      Department of Internal Medicine III, Erasmus University Medical Center, Rotterdam, The Netherlands

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Frank H de Jong is among the top experts in the world.
      Concept World rank
      4 years inhibin #1
      inhibin cultured #1
      inhibin lower testosterone #1
      gast rocauc #1
      bff injection #1
      amh null #1
      intact male ferrets #1
      38 patients nfas #1
      retrospective study cryptorchidism #1
      fsh estrus #1
      fsh adult female #1
      improvement spermatogenesis #1
      cycle ivf treatment #1
      ferrets deslorelin implant #1
      aga boys inhibin #1
      mice analogue #1
      proestrus 0030 #1
      cells patient tissues #1
      nsbt boys #1
      cyp17 inhibin alpha #1
      underlying etiology 31 #1
      deoxycorticosterone levels concentrations #1
      fsh concentration cryptorchid #1
      patient tissues activin #1
      serum cortisol pcs #1
      patients minimal incidence #1
      ru486 canrenoate #1
      lh unilateral ovariectomy #1
      gast variables #1
      novo steroid synthesis #1
      2 lhrh #1
      followup adrenocortical carcinoma #1
      tumor cells acth #1
      motility serum zinc #1
      sleeprelated breathing polysomnography #1
      phase fsh #1
      17hydroxypregnenolone 11deoxycortisol #1
      neoplasms humans pof #1
      aga inhibin #1
      cushings syndrome levoketoconazole #1
      ketoconazole steroidogenesis inhibitors #1
      angii acc #1
      akr1c3 levels #1
      endocrine effects tbbpa #1
      fertility potential audt #1
      normalization fsh #1
      afc ccct #1
      acth mrap #1
      netherlands heterozygote frequency #1
      gast predictor #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Frank H de Jong

      KOL-Index: 14479

      Although ovarian follicle growth is under the influence of many growth factors and hormones of which FSH remains one of the most prominent regulators. Therefore, factors affecting the sensitivity of ovarian follicles to FSH are also important for follicle growth. The aim of the present study was to investigate whether anti-Müllerian hormone (AMH) has an inhibitory effect on follicle growth by decreasing the sensitivity of ovarian follicles to FSH. Furthermore, the combined action of AMH ...

      Known for Amh Fsh | Follicle Development | Mouse Ovary | Hormone Growth | Inbred C57bl Mice
      KOL-Index: 14074

      OBJECTIVE: Age at menopause and age at the start of the preceding period of cycle irregularity (menopausal transition) show considerable individual variation. In this study we explored several markers for their ability to predict the occurrence of the transition to menopause.

      DESIGN: A group of 81 normal women between 25 and 46 years of age visited the clinic two times (at T1 and T2) with an average interval of 4 years. All had a regular menstrual cycle pattern at T1. At T1, ...

      Known for Menopausal Transition | Age Amh | Fsh Inhibin | Cycle Irregularity | Müllerian Hormone
      KOL-Index: 13949

      Anti-Müllerian hormone (AMH) concentrations correlate with the number of antral follicles as well as age and constitute an endocrine marker for ovarian aging. In normogonadotropic anovulatory infertile women [World Health Organization (WHO) class 2], the number of early antral follicles is usually increased. To investigate whether AMH concentrations are increased, serum levels in 128 WHO 2 women were compared with those in 41 normoovulatory premenopausal women of similar age. Serum AMH ...

      Known for Serum Concentrations | Reproductive Age | Patients Pcos | Hormone Ovarian | Health Organization
      KOL-Index: 13714

      OBJECTIVE: The growth and differentiation factors activin and inhibin can affect tumour formation and steroid production in the adrenal cortex. These factors bind to type I (Alk-4), type II (ActRIIA, ActRIIB) and type III (betaglycan) receptors or to the activin-binding protein follistatin. Expression of these activin-related mRNAs was measured in different types of adrenocortical tissues and tumours to study the relationship with tumorigenesis.

      DESIGN: Quantitative expression of ...

      Known for Binding Proteins | Inhibin Subunits | Adrenocortical Neoplasms | Expression Activin | Transforming Growth Factor
      KOL-Index: 13663

      Dogs of different ages without testicular diseases were evaluated to study possible age-related changes in hormone concentrations in serum. Dogs with testicular tumours were also investigated to study the relation between tumour type and hormone concentrations; in this study, dogs with Sertoli cell tumours, Leydig cell tumours and seminomas were included. We measured testosterone, oestradiol, LH, FSH and inhibin-like immunoreactivity concentrations in peripheral venous and testicular ...

      Known for Testicular Tumours | Normal Dogs | Sertoli Cell | Lh Fsh | Hormone Concentrations
      KOL-Index: 13645

      BACKGROUND: The aim of this study was to investigate the predictive accuracy and clinical value of performing either a single or a repeated clomiphene citrate challenge test (CCCT) in predicting poor response in IVF, compared to that of currently used basal ovarian reserve markers.

      METHODS: Sixty-three patients undergoing their first IVF treatment were prospectively included. After measurement of basal markers on cycle day 3 (cd3) [FSH, inhibin B and antral follicle count (AFC)], a CCCT ...

      Known for Ovarian Reserve | Poor Response | Afc Ccct | Ivf Treatment | Fsh Inhibin
      KOL-Index: 13407

      BACKGROUND: The purpose of this study was to compare the predictive capacity of several markers of reproductive age in normal women.

      METHODS: Healthy female volunteers (n = 162) aged 25-46 years with proven, normal fertility and regular menstrual cycles were recruited. In this selected group, chronological age was assumed to approximate reproductive age and, therefore, was taken as the proxy-variable for reproductive age. The number of antral follicles with 2-10 mm diameter, total ...

      Known for Reproductive Age | Antral Follicles | Normal Women | Proven Fertility | Ovarian Follicle
      KOL-Index: 13250

      Effects of follicle-stimulating hormone (FSH) and insulin-like growth factor-I (IGF-I) on inhibin production by cultured Sertoli cells from 21- to 23-day-old rats were studied. The expression of inhibin alpha- and beta-subunit mRNAs, and inhibin immunoreactivity and in vitro bioactivity were estimated. Using a cDNA probe corresponding to the alpha-subunit of bovine inhibin, specific hybridization with a 1.5-1.7 kilobase (kb)mRNA species was observed. Addition of FSH to the cultured ...

      Known for Subunit Mrna | Inhibin Secretion | Sertoli Cells | Messenger Rats | Insulinlike Growth Factor
      KOL-Index: 13199

      CONTEXT: Ovarian dysfunction is classically categorized on the basis of cycle history, FSH, and estradiol levels. Novel ovarian markers may provide a more direct insight into follicular quantity in hypergonadotropic women.

      OBJECTIVE: The objective of the study was to investigate the distribution of novel ovarian markers in young hypergonadotropic women as compared with normogonadotropic regularly menstruating women.

      DESIGN: This was a nationwide prospective cohort study.

      SETTING: The ...

      Known for Young Women | Ovarian Failure | Antral Follicle Count | Amh Levels | Mullerian Hormone

      Key People For Glucocorticoid Receptor

      Top KOLs in the world
      #1
      Jan Aake ÂKE GUSTAFSSON
      estrogen receptor rat liver cytochrome p450
      #2
      John Anthony Cidlowski
      glucocorticoid receptor cell death concise guide
      #3
      Keith R Yamamoto
      glucocorticoid receptor dna binding mammary tumor
      #4
      Ronald M Evans
      nuclear receptors retinoic acid gene expression
      #5
      Günther Schütz
      glucocorticoid receptor transgenic mice gene expression
      #6
      George Panagiotis Chrousos
      glucocorticoid receptor releasing hormone insulin resistance

      Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands | Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands | Division of Endocrinology, Department

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.